Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Morepen Laboratories Ltd

+ Add to Watchlist

MORE:IN

9.75 INR 0.05 0.52%

As of 00:16:18 ET on 01/28/2015.

Snapshot for Morepen Laboratories Ltd (MORE)

Open: 9.65 Day's Range: 9.58 - 9.90 Volume: 168,430
Previous Close: 9.70 52wk Range: 3.40 - 17.58 1-Yr Rtn: +140.74%

Stock Chart for MORE

No chart data available.
  • MORE:IN 9.75
  • 1D
  • 1M
  • 1Y
9.70
Interactive MORE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MORE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) -0.1260
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 2,943.96
Shares Outstanding (M) 303.50
30 Day Average Volume 910,823
Price/Book (mrq) 2.4713
Price/Sale (ttm) 1.1955
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.6000
Dividend Ex-Date 09/18/2002
5 Year Dividend Growth -
Next Earnings Announcement 05/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MORE

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for MORE

Morepen Laboratories Limited develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company's products are available in a variety of formulations, including tablets, capsules, injections, ointments, syrups, and powders. Morepen's products include Loratadine, Fluvastatin, Montelukast, and Fexofenadine.

Sushil SuriChairman/Managing DirectorSanjay SharmaExecutive Director
Ajay Kumar SharmaCFO/Gen Mgr:Finance & AccountsArun Kumar SinhaDir:Technical
More Company Profile & Key Executives for MORE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil